UV-VIS Instrument Replacement

The contract involves the replacement of ultraviolet-visible (UV-VIS) instrumentation that has been in use for 30 years and has reached the end of its serviceable life. These instruments are crucial analytical tools used in laboratory settings, and maintaining this equipment is essential to preserve the agency’s ongoing analytical functions. The replacement ensures that the necessary operational capacity and precision in laboratory analyses are sustained without interruption. This opportunity is managed by the Food and Drug Administration under the NAICS code 541990 and is currently listed as a forecast with no set-aside status indicated. Although specific location details and contracting officer information are yet to be determined, interested parties can direct inquiries to the program point of contact via the provided FDA acquisition email. The contract posting date is March 11, 2026, signaling upcoming activity related to procurement for critical laboratory instrumentation upgrades.